Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Juliet Ndukum"'
Autor:
Christian Bime, Nancy G. Casanova, Sara M. Camp, Radu C. Oita, Juliet Ndukum, Vivian Reyes Hernon, Dong Kyu Oh, Yansong Li, Phil J. Greer, David C. Whitcomb, Georgios I. Papachristou, Joe G. N. Garcia
Publikováno v:
BMC Anesthesiology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Nicotinamide phosphoribosyltransferase (NAMPT) exhibits dual functionality – as an intracellular enzyme regulating nicotinamide adenine dinucleotide metabolism and as an extracellular secreted protein (eNAMPT) to function as a c
Externí odkaz:
https://doaj.org/article/4a9a6cb92cbb42b3867fe595c78e81c3
Autor:
Christian Bime, Nancy Casanova, Radu C. Oita, Juliet Ndukum, Heather Lynn, Sara M. Camp, Yves Lussier, Ivo Abraham, Darrick Carter, Edmund J. Miller, Armand Mekontso-Dessap, Charles A. Downs, Joe G. N. Garcia
Publikováno v:
Critical Care, Vol 23, Iss 1, Pp 1-8 (2019)
Abstract Background There is a compelling unmet medical need for biomarker-based models to risk-stratify patients with acute respiratory distress syndrome. Effective stratification would optimize participant selection for clinical trial enrollment by
Externí odkaz:
https://doaj.org/article/8c1eaba7dd3746b489d4bff3574dabaa
Autor:
Roger M. Lyons, Kathleen M. Aguilar, Lavanya Sudharshan, Divea Venkatasetty, Juliet Ndukum, Ira Zackon, Jingbo Yu
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22
Cytoreduction with hydroxyurea (HU) is the recommended first-line (1L) treatment for high-risk PV (age ≥60 years; history of thrombosis), but many patients have a suboptimal response.To describe characteristics, blood counts, treatments, and clinic
Autor:
Roger M. Lyons, Kathleen M. Aguilar, Lavanya Sudharshan, Divea Venkatasetty, Juliet Ndukum, Ira Zackon, Jingbo Yu
Publikováno v:
Blood. 140:13310-13311
Autor:
David J. Mellert, Carmen M. Foster, Jason A. Bubier, Elissa J. Chesler, Tatiana A. Vishnivetskaya, George M. Weinstock, Vivek M. Philip, Yanjiao Zhou, Kevin D. Donohue, Suman Duvvuru, Cymbeline T. Culiat, Mircea Podar, Anthony V. Palumbo, Juliet Ndukum, James H. Campbell, Rachel Blair, Bruce F. O'Hara, Christopher Quince
Publikováno v:
Genetics
Host genetic diversity provides a variable selection environment and physiological context for microbiota and their interaction with host physiology. Using a highly diverse mouse population, Bubier et al. identified that Odoribacter abundance influen
Autor:
Sara M. Camp, Yves A. Lussier, Juliet Ndukum, Nancy Casanova, Christian Bime, Charles A. Downs, Joe G.N. Garcia, Ivo Abraham, Edmund J. Miller, Armand Mekontso-Dessap, Radu C. Oita, Darrick Carter, Heather Lynn
Publikováno v:
Critical Care, Vol 23, Iss 1, Pp 1-8 (2019)
Critical Care
Critical Care
Background There is a compelling unmet medical need for biomarker-based models to risk-stratify patients with acute respiratory distress syndrome. Effective stratification would optimize participant selection for clinical trial enrollment by focusing
Autor:
Roger M. Lyons, Kathleen M. Aguilar, Lavanya Sudharshan, Divea Venkatasetty, Juliet Ndukum, Ira Zackon, Jingbo Yu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S156
Autor:
Christian Bime, Nancy Gonzalez Casanova, Sara M. Camp, Radu C. Oita, Juliet Ndukum, Vivian Reyes Hernon, Dong Kyu Oh, Yansong Li, Phil J. Greer, David C Whitcomb, Georgios I. Papachristou, Joe G. N. Garcia
Background: Nicotinamide phosphoribosyltransferase (NAMPT) is a protein that exhibits dual functionality – as an intracellular enzyme which regulates nicotinamide adenine dinucleotide metabolism and as an extracellular protein (eNAMPT) secreted int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b9e62719a445c88282af24292433a4b
https://doi.org/10.21203/rs.3.rs-847354/v1
https://doi.org/10.21203/rs.3.rs-847354/v1
Autor:
Roger M. Lyons, Kathleen M. Aguilar, Lavanya Sudharshan, Divea Venkatasetty, Juliet Ndukum, Ira Zackon, Jingbo Yu
Publikováno v:
Journal of Clinical Oncology. 40:e19076-e19076
e19076 Background: Cytoreduction with hydroxyurea (HU) is the recommended first-line (1L) treatment for high-risk PV (age ≥60 y or history of thrombosis), but many pts have a suboptimal response on HU. The objective of this study was to describe ch
Autor:
Gregory W. Carter, Michael A. Langston, Narayanan Raghupathy, Gary A. Churchill, Charles A. Phillips, Raymond F. Robledo, Matthew A. Hibbs, Daniel M. Gatti, Joel H. Graber, Troy Wilcox, Elissa J. Chesler, Ann E. Wells, Steven C. Munger, Juliet Ndukum
Publikováno v:
Alzheimer's & Dementia. 16